VYNE Therapeutics Inc. — Director's Dealing 2021

Jul 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VYNE Therapeutics Inc. (VYNE)
CIK: 0001566044
Period of Report: 2021-07-19

Reporting Person: Basta Steven L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-19	Stock Options	$2.75	A	20500	Acquired	2031-07-19	Common Stock (20500)	Direct

Footnotes

F1: These options vest over a 12 month period in equal, monthly installments, ending July 19, 2022.